Literature DB >> 13305751

[Problem of the mechanism of origin of circulatory collapse in acute pancreatic necrosis].

M M FORELL.   

Abstract

Entities:  

Keywords:  PANCREATITIS/experimental; SHOCK/experimental; TRYPSIN/effects

Mesh:

Substances:

Year:  1955        PMID: 13305751

Source DB:  PubMed          Journal:  Gastroenterologia        ISSN: 0301-164X


× No keyword cloud information.
  7 in total

1.  [ON THE EFFECT OF SECRETIN AND PANCREOZYMIN ON THE EXCRETORY FUNCTION OF THE PANCREAS AND THEIR DIAGNOSTIC POSSIBILITIES].

Authors:  M M FORELL; H STAHLHEBER
Journal:  Klin Wochenschr       Date:  1964-07-15

2.  [Research on the inhibitory property of the blood toward trypsin and its control by intravenous administration of kallikrein and trypsin gland inactivators].

Authors:  M M FORELL; W DOBOVICNIK
Journal:  Blut       Date:  1961-07

3.  [On the possibility of causal modification of acute pancreatitis by inactivation of trypsin].

Authors:  M M FORELL; W DOBOVICNIK
Journal:  Klin Wochenschr       Date:  1961-01-01

4.  [On possibilities and limitations of the diagnosis of acute and chronic pancreas diseases on the basis of diastase, lipase and trypsin determinations].

Authors:  M M FORELL; W DOBOVICNIK
Journal:  Klin Wochenschr       Date:  1959-10-01

5.  Mechanism of blood enzyme changes following the production of experimental pancreatitis.

Authors:  R H EGDAHL
Journal:  Ann Surg       Date:  1958-09       Impact factor: 12.969

6.  Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats.

Authors:  Thomas Griesbacher; Irmgard Rainer; Beate Tiran; D Michael Evans
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

7.  Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.

Authors:  T Griesbacher; B Tiran; F Lembeck
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.